TYMS and cancer: Retrospective research showed that in M1a stage cancer, reduced thymidylate synthase levels, lower levels of CEA at baseline, and the return of CEA levels to normal after treatment with Pem-Cis (pemetrexed plus cisplatin) were indicators of a sustained positive response to pemetrexed maintenance therapy (56).